Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Pancreatic Neoplasms 1 Obesity, Morbid 1 Obesity 1 Fistula 1 Esophageal Neoplasms 1 Duodenal Neoplasms 1 Colonic Neoplasms 1 Bile Duct Neoplasms 1 Anastomotic Leak 1

Interventions

Gemcitabine 11 Cisplatin 10 pembrolizumab 5 Oxaliplatin 4 durvalumab 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Fluorouracil 3 tivozanib 2 Specimen Handling 2 Capecitabine 2 zimberelimab 1 trametinib 1 tislelizumab 1 quemliclustat 1 pertuzumab 1 olaparib 1 irinotecan sucrosofate 1 atezolizumab 1 anlotinib 1 Yttrium-90 1 Tissue Adhesives 1 Tegafur 1 Stents 1 S 1 (combination) 1 Ritonavir 1 Radiosurgery 1 Pancreaticojejunostomy 1 Pancreaticoduodenectomy 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bile Duct Neoplasms × Stents × 1 year × Clear all

NCT06274879 2026-05-26

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡